Catalyst Pharmaceutical Partners (CPRX) in Focus: Stock Moves 6.2% Higher - Tale of the Tape

By Zacks Equity Research,

Shutterstock photo

Catalyst Pharmaceutical Partners Inc. ( CPRX ) was a big mover last session, as the company saw its shares rise by over 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session.  This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $2.05 to $2.33 in the past one-month time frame.

This drug manufacturer has seen no estimate revision over the past 30 days and its Zacks Consensus Estimate remained unchanged over the same time frame. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Catalyst Pharmaceutical Partners currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Some better-ranked stocks in the same industry include Lannett Company, Inc. ( LCI ), Questcor Pharmaceuticals, Inc. ( QCOR ) and Shire plc ( SHPG ). All these stocks hold a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

CATALYST PHARMA (CPRX): Free Stock Analysis Report

LANNETT INC (LCI): Free Stock Analysis Report

QUESTCOR PHARMA (QCOR): Free Stock Analysis Report

SHIRE PLC-ADR (SHPG): Free Stock Analysis Report

To read this article on click here.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

This article appears in: Investing , Investing Ideas , Stocks
Referenced Stocks: CPRX , LCI , QCOR , SHPG

More from


Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by